Added NNOS on news of teaming up with Amex company. Now +21% to .097. Tuesday April 20, 11:24 am ET
LAS VEGAS, NV--(MARKET WIRE)--Apr 20, 2004 -- NanoSignal Corp. (formerly MicroSignal Corp.) (OTC BB:NNOS.OB - News) announced today that a letter of intent has been approved by the Board of Directors to complete a business combination with a targeted American Stock Exchange (AMEX) listed company. The Board appointed Scott A. Ervin, CEO with the responsibility to successfully complete the negotiation process.
ADVERTISEMENT
The negotiations will be geared to create a business combination whereby the AMEX listed company will offer an exchange of its shares for the shares of NNOS and several targeted roll-up companies. The business combination will be managed by an expanded Board of Directors with each roll-up entity operating on a subsidiary basis. The combined roll-up will have the assets, cash flow, market capitalization and share holder distribution base for AMEX listing. A discrete portion of existing assets and liabilities will be down-streamed in a spin-off to the existing AMEX shareholders through the issuance of preferred shares while retaining a portfolio investment in the AMEX company post roll-up.
With considerable financial negotiation success throughout his career, CEO Ervin states, "I joined NanoSignal with a mission statement to fully commercialize the company's Slices(TM) technology serving the MRI industry. AMEX listing is merely another step in the process I started when I joined NanoSignal in February 2004. We remain committed to building shareholder value."
About NanoSignal Corp.
NanoSignal Corp. is a medical technology company introducing its patented Slices(TM) technology to the MRI industry, allowing radiologists and technologists to perform advanced imaging features beyond the capabilities of the standard MRI computer.
Information about NanoSignal Corp. is available at www.nanosignalcorp.com.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." These statements are not guarantees of future performance and involve significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statements as a result of the effectiveness of management's strategies and decisions, general economic and business conditions, new or modified statutory or regulatory requirements, and changing price and market conditions. No assurance can be given that these are all the factors that could cause actual results to vary materially from the forward-looking statement.
Contact:
Contact:
Juan Ferreira
407-774-9949
Princeton Research Inc.
Michael King
702-650-3000
--------------------------------------------------------------------------------
Source: NanoSignal Corporation, Inc
News 
Market Data 
Discover 
AI
